Please note, this OEL/ADE monograph also applies to dexamethasone acetate (CAS RN 1177-87- 3), dexamethasone acetate monohydrate (CAS RN 55812-90-3) and dexamethasone sodium phosphat e (CAS RN 2392-39-4). The indications for dexamethasone, an adrenal glucocor ticoid, are allergic disorders, tumor associated brain swelling, collagen disease, Cushing’ s syndrome, endocrine system disorders, eye disorders, GI tract disorders, hematopo ietic structure disorder, respiratory system disorder, skin disorder, multiple sclerosi s, high calcium from cancer, idiopathic blood cell changes, muscle inflammation, retinal swelling, multiple lymphomas, multiple leukemias, kidney disorder, eye inflamma tion.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value and the acceptable surface limit (ASL).
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Dexamethasone, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.